AstraZeneca (AZN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist

66.260
-0.260-0.39%

Close Dec 27 16:00 ET

66.270
+0.010+0.02%

Post 20:01 ET

205.45BMarket Cap31.93P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Seeking AlphaDec 28 10:31 ET
Astrazeneca (AZN) Stock Moves -0.39%: What You Should Know
Yahoo FinanceDec 27 18:15 ET
Daiichi Sankyo Gets Japanese Approval for Datroway
Seeking AlphaDec 27 10:52 ET
Here's Why Astrazeneca (AZN) Is a Strong Value Stock
Yahoo FinanceDec 27 09:40 ET
Syncona: Achilles Announces Sale Of Technology Assets To AstraZeneca - Quick Facts
RTTNewsDec 27 02:12 ET
Achilles Therapeutics Sells Key Assets to AstraZeneca
TipRanksDec 27 02:08 ET

Comments

Meltyy

Dec 17 01:56

📌 1 PDUFA this weekand 6 more upcoming this month! 🚀

🔔 This Week’s PDUFA:
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...

10xStockPicks

Dec 15 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

10xStockPicks

Dec 15 15:56

Buying This Takeover Target Offers 10X Upside. Esperion Therapeutics.

$Esperion Therapeutics (ESPR.US)$ $Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics (ESPR) is a biotech company that focuses on developing and commercializing therapies to lower cholesterol, specifically offering the only FDA-approved statin alternatives: NEXLIZET and NEXLETOL for PRIMARY PREVENTION. These drugs are designed for individuals who are statin intolerant or cannot achieve adequate cholesterol lowering with statin...